Richard Pas­coe takes the helm at His­to­gen; Lon­za COO steps up at CEO Richard Ridinger re­tires

→ Hav­ing hand­ed off trou­bled mi­cro­cap biotech Apri­cus Bio­sciences to See­los Ther­a­peu­tics via a merg­er, Richard Pas­coe is mov­ing on to his next CEO (and chair­man) gig at His­to­gen. The re­gen­er­a­tive med­i­cine de­vel­op­er is an­tic­i­pat­ing da­ta from a clin­i­cal tri­al in fe­male hair loss this year, and the board likes Pas­coe’s ex­pe­ri­ence in both fundrais­ing and reg­u­la­to­ry deal­ings. Pas­coe al­so ap­pears to have a pen­chant for com­pa­nies that get ab­sorbed, in­clud­ing So­max­on Phar­ma, Ari­ad and Pfiz­er-ac­quired King Phar­ma.  

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.